Novabay Pharmaceuticals (NBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 6,599 | 12,508 | 18,230 | 11,897 | 4,381 |
| Cost of Goods | 1,738 | 1,503 | 2,784 | 2,464 | 1,261 |
| Gross Profit | 4,861 | 11,005 | 15,446 | 9,433 | 3,120 |
| Operating Expenses | 14,999 | 19,379 | 23,541 | 20,879 | 24,518 |
| Operating Income | -9,400 | -7,871 | -7,311 | -10,982 | -21,137 |
| Other Income | -252 | 1,330 | -89 | -2,167 | 2,166 |
| Pre-tax Income | -9,652 | -6,541 | -7,400 | -13,149 | -18,971 |
| Income Tax | -6 | -4 | -3 | -2 | 2 |
| Net Income Continuous | -9,646 | -6,537 | -7,397 | -13,147 | -18,973 |
| Net Income | $-9,646 | $-6,537 | $-7,397 | $-13,147 | $-18,973 |
| EPS Basic Total Ops | -586.83 | -476.80 | -586.83 | -1,711.58 | -8,337.82 |
| EPS Basic Continuous Ops | -544.93 | -472.30 | -590.14 | -1,708.43 | -8,331.72 |
| EPS Diluted Total Ops | -586.83 | -562.37 | -586.83 | -1,711.58 | -8,337.82 |
| EPS Diluted Continuous Ops | -544.93 | -468.51 | -590.14 | -1,708.43 | -8,331.72 |
| EPS Diluted Before Non-Recurring Items | -586.83 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-9,335 | $-7,605 | $-7,216 | $-10,868 | $-20,973 |